Mercer Global Advisors Inc Supernus Pharmaceuticals, Inc. Transaction History

Mercer Global Advisors Inc

$58.7 Billion
Q3 2025

A detailed history of Mercer Global Advisors Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 9,248 shares of SUPN stock, worth $416,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,248

Previous 11,674 20.78%

Holding current value

$416,160

Previous $367,000 20.16%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$31.45 - $47.79 $76,297 - $115,938	-2,426 Reduced 20.78%	9,248 $441,000
Q2 2025 Aug 14, 2025	BUY	$30.29 - $33.43 $47,252 - $52,150	1,560 Added 15.42%	11,674 $367,000
Q1 2025 May 15, 2025	SELL	$31.17 - $40.0 $2,026 - $2,600	-65 Reduced 0.64%	10,114 $331,000
Q4 2024 Feb 14, 2025	SELL	$31.89 - $37.83 $29,370 - $34,841	-921 Reduced 8.3%	10,179 $368,000
Q3 2024 Nov 13, 2024	SELL	$25.77 - $35.16 $7,550 - $10,301	-293 Reduced 2.57%	11,100 $346,000

Q2 2024 Aug 12, 2024	SELL	$25.99 - $33.85 $18,712 - $24,372	-720 Reduced 5.94%	11,393 $304,000
Q1 2024 May 15, 2024	BUY	$27.11 - $35.17 $21,986 - $28,522	811 Added 7.18%	12,113 $413,000
Q4 2023 Feb 14, 2024	SELL	$22.72 - $29.68 $1,045 - $1,365	-46 Reduced 0.41%	11,302 $327,000
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $3,749 - $4,475	-136 Reduced 1.18%	11,348 $313,000
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $31,943 - $41,363	1,068 Added 10.25%	11,484 $345,000
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $9,186 - $11,053	263 Added 2.59%	10,416 $377,000
Q4 2022 Feb 08, 2023	SELL	$31.09 - $37.88 $79,932 - $97,389	-2,571 Reduced 20.21%	10,153 $362,000
Q3 2022 Nov 15, 2022	BUY	$28.79 - $35.41 $14,682 - $18,059	510 Added 4.18%	12,724 $431,000
Q2 2022 Aug 10, 2022	BUY	$25.33 - $34.25 $810 - $1,096	32 Added 0.26%	12,214 $353,000
Q1 2022 May 10, 2022	BUY	$28.51 - $32.9 $66,770 - $77,051	2,342 Added 23.8%	12,182 $394,000
Q4 2021 Feb 04, 2022	BUY	$26.37 - $34.22 $8,306 - $10,779	315 Added 3.31%	9,840 $287,000
Q3 2021 Nov 10, 2021	SELL	$23.54 - $31.39 $7,344 - $9,793	-312 Reduced 3.17%	9,525 $254,000
Q2 2021 Aug 10, 2021	BUY	$26.72 - $33.19 $262,844 - $326,490	9,837 New	9,837 $303,000

Others Institutions Holding SUPN

# of Institutions

331

Shares Held

60.5M

Call Options Held

234K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.41B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Supernus Pharmaceuticals, Inc. Transaction History